At Manningham Medical Centre, you can find all the data about Diamyd Medical Sr B. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Diamyd Medical - Developing precision therapies for type …

    https://www.diamyd.com/
    Year-end report 2022/2023. Our pipeline for autoimmune diabetes is potentially game changing. Focusing on safe and specific interventions that have the promise to realize the …

DMYD.B | Diamyd Medical AB Series B Stock Price & News - WSJ

    https://www.wsj.com/market-data/quotes/SE/XSTO/DMYD.B
    View the latest Diamyd Medical AB Series B (DMYD.B) stock price, news, historical charts, analyst ratings and financial information from WSJ. DMYD.B | Diamyd Medical AB …

Diamyd Medical AB Class B DMYD B Stock Quote

    https://www.morningstar.com/stocks/xsto/dmyd%20b/quote
    Diamyd Medical AB is a Sweden based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic …

Diamyd Medical AB Class B DYMDF Stock Quote

    https://www.morningstar.com/stocks/grey/dymdf/quote
    Diamyd Medical AB is a Sweden based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic …

Investor Relations - Diamyd

    https://www.diamyd.com/docs/Investors.aspx
    Spearheaded by Diamyd ®, an antigen-specific immunotherapy for individuals carrying a common risk gene (haplotype DR3-DQ2”), provides us with the opportunity to …

Diamyd Medical AB (publ) (DMYD-B.ST) - Yahoo!

    https://finance.yahoo.com/quote/DMYD-B.ST
    Diamyd Medical AB (publ) (DMYD-B.ST) Stockholm - Stockholm Real Time Price. Currency in SEK Follow 16.25 +0.16 (+0.99%) At close: 05:29PM CET 1d 5d 1m 6m YTD …

Diamyd Medical OM:DMYD B Stock Report - Simply Wall St

    https://simplywall.st/stocks/se/pharmaceuticals-biotech/sto-dmyd-b/diamyd-medical-shares
    The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase III clinical trial for the treatment of type 1 diabetes …

Diamyd Medical AB (publ) (DMYD-B.ST) - Yahoo!

    https://finance.yahoo.com/quote/DMYD-B.ST/profile/
    The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase III clinical trial for the treatment of type 1 diabetes and latent …



Need more information about Diamyd Medical Sr B?

At Manningham Medical Centre, we collected data on more than just Diamyd Medical Sr B. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.